Cover Story
Guest Editorial
One day in 1996, in my role as chief science correspondent for NBC News, I was rummaging through the usual huge (pre-internet) pile of press releases on my desk and zeroed in on one: a phase III trial of a treatment for an aggressive type of breast cancer that was desperate to accrue volunteers.
In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- Radiation oncologist, global health expert C. Norman Coleman dies of sarcoma at 79
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Kathy Giusti’s “Fatal to Fearless” memoir tells the story of prevailing over multiple myeloma
Book offers 12 steps to beating cancer in a broken medical system - Population scientist Monica Baskin is the “Jackie Robinson” of cancer center deputy directors
- Biden’s State of the Union highlights healthcare wins in cancer
White House announces ARPA-H precision cancer therapy program and patient navigation commitments - CMS starts paying for patient navigation; ACS offers navigation credentialing program